Search by Drug Name or NDC
NDC 50102-0400-10 Lidocaine Hydrochloride 10 mg/mL Details
Lidocaine Hydrochloride 10 mg/mL
Lidocaine Hydrochloride is a INFILTRATION; PERINEURAL INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Afaxys Pharma LLC. The primary component is LIDOCAINE HYDROCHLORIDE.
Product Information
| NDC | 50102-0400 |
|---|---|
| Product ID | 50102-400_4906a1e0-c3aa-48e3-8915-00f2e607185a |
| Associated GPIs | |
| GCN Sequence Number | 003404 |
| GCN Sequence Number Description | lidocaine HCl VIAL 10 MG/ML INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 11854 |
| HICL Sequence Number | 001478 |
| HICL Sequence Number Description | LIDOCAINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Lidocaine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | lidocaine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INFILTRATION; PERINEURAL |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | LIDOCAINE HYDROCHLORIDE |
| Labeler Name | Afaxys Pharma LLC |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215132 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50102-0400-10 (50102040010)
| NDC Package Code | 50102-400-10 |
|---|---|
| Billing NDC | 50102040010 |
| Package | 10 VIAL, MULTI-DOSE in 1 TRAY (50102-400-10) / 20 mL in 1 VIAL, MULTI-DOSE (50102-400-01) |
| Marketing Start Date | 2022-06-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |